ARTICLE | Company News
OSI, Merck deal
June 19, 2000 7:00 AM UTC
The companies signed a worldwide non-exclusive cross-licensing agreement covering OSIP's gene transcription technology, acquired in 1999 from Cadus Pharmaceuticals Corp. (KDUS, Tarrytown, N.Y.), and M...